Literature DB >> 20473001

Cytokine adsorbing columns.

Takumi Taniguchi1.   

Abstract

Sepsis induces the activation of complement and the release of inflammatory cytokines such as TNF-alpha and IL-1beta. The inflammatory cytokines and nitric oxide induced by sepsis can decrease systemic vascular resistance, resulting in profound hypotension. The combination of hypotension and microvascular occlusion results in tissue ischemia and ultimately leads to multiple organ failure. Recently, several experimental and clinical studies have reported that treatment for adsorption of cytokines is beneficial during endotoxemia and sepsis. Therefore, the present article discusses cytokine adsorbing columns. These columns, such as CytoSorb, CYT-860-DHP, Lixelle, CTR-001 and MPCF-X, the structures of which vary significantly, have excellent adsorption rates for inflammatory cytokines such as TNF-alpha, IL-1beta, IL-6 and IL8. Many studies have demonstrated that treatment with cytokine adsorbing columns has beneficial effects on the survival rate and inflammatory responses in animal septic models. Moreover, several cases have been reported in which treatment with cytokine adsorbing columns is very effective in hemodynamics and organ failures in critically ill patients. Although further investigations and clinical trials are needed, in the future treatment with cytokine adsorbing columns may play a major role in the treatment of hypercytokinemia such as multiple organ failure and acute respiratory distress syndrome. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20473001     DOI: 10.1159/000314863

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  6 in total

1.  Biomarkers of sepsis, a never-ending story.

Authors:  Simona Mărgărit
Journal:  Rom J Anaesth Intensive Care       Date:  2014-10

2.  CytoSorb-friend or foe!!

Authors:  Saroj Kumar Pattnaik; Bibekananda Panda
Journal:  Indian J Crit Care Med       Date:  2015-05

Review 3.  Opportunities for biomaterials to address the challenges of COVID-19.

Authors:  Daniel Chakhalian; Robert B Shultz; Catherine E Miles; Joachim Kohn
Journal:  J Biomed Mater Res A       Date:  2020-08-04       Impact factor: 4.854

Review 4.  Sepsis: From Pathophysiology to Individualized Patient Care.

Authors:  Ildikó László; Domonkos Trásy; Zsolt Molnár; János Fazakas
Journal:  J Immunol Res       Date:  2015-07-15       Impact factor: 4.818

5.  Effectiveness of Multiple Blood-Cleansing Interventions in Sepsis, Characterized in Rats.

Authors:  Ivan Stojkovic; Mohamed Ghalwash; Xi Hang Cao; Zoran Obradovic
Journal:  Sci Rep       Date:  2016-04-21       Impact factor: 4.379

6.  RECCAS - REmoval of Cytokines during CArdiac Surgery: study protocol for a randomised controlled trial.

Authors:  Andreas Baumann; Dirk Buchwald; Thorsten Annecke; Martin Hellmich; Peter K Zahn; Andreas Hohn
Journal:  Trials       Date:  2016-03-12       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.